Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers

scientific article

Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/10799893.2015.1072976
P698PubMed publication ID26459714

P50authorJean-Martin BeaulieuQ30513917
P2093author name stringThomas Del' Guidice
P2860cites workA beta-arrestin 2 signaling complex mediates lithium action on behaviorQ24306355
Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice.Q48437323
Automated tests for measuring the effects of antidepressants in miceQ48963867
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behaviorQ24310712
A molecular mechanism for the effect of lithium on developmentQ24629067
Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophreniaQ28254349
Neural and developmental actions of lithium: a unifying hypothesisQ28254375
Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibitionQ28468536
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivoQ28512114
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogenQ29616224
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?Q30475816
Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviourQ30522548
A common mechanism of action for three mood-stabilizing drugsQ34128871
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic DrugsQ34192438
Molecular targets of lithium actionQ34192797
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiencyQ34587440
Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neuronesQ35026378
Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neuronsQ35563894
Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortexQ37088689
Behavioral phenotyping strategies for mutant miceQ37119401
Pharmacotherapy of mood disordersQ37120683
Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?Q37227483
Akt/GSK3 signaling in the action of psychotropic drugsQ37301265
Looking at lithium: molecular moods and complex behaviourQ37327911
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascadeQ37416273
D2 dopamine receptors interact directly with N-type calcium channels and regulate channel surface expression levelsQ39948331
Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithiumQ40262756
Confocal Analysis of Cholinergic and Dopaminergic Inputs onto Pyramidal Cells in the Prefrontal Cortex of RodentsQ41494857
Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat.Q42459019
Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive miceQ42500923
Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithiumQ44264546
Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathwaysQ44273064
Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine systemQ44315070
Convergent evidence for impaired AKT1-GSK3beta signaling in schizophreniaQ44743796
Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis.Q44989787
Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptorsQ46841675
Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated miceQ48161085
Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviorsQ48273410
P433issue3
P921main subjectdopamineQ170304
P304page(s)224-232
P577publication date2015-10-12
P1433published inJournal of Receptors and Signal TransductionQ6295837
P1476titleSelective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers
P478volume35

Reverse relations

cites work (P2860)
Q61449987Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
Q90282737Contribution of neuronal calcium sensor 1 (Ncs-1) to anxiolytic-like and social behavior mediated by valproate and Gsk3 inhibition
Q48474387Converging evidence for regulation of dopamine neurotransmission by lithium: An Editorial Highlight for 'Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens'.
Q30368373Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia.
Q64098909HDAC6 Modulates Signaling Pathways Relevant to Synaptic Biology and Neuronal Differentiation in Human Stem-Cell-Derived Neurons
Q57183263High Sensitivity Mapping of Cortical Dopamine D2 Receptor Expressing Neurons
Q48056810Inositol depletion, GSK3 inhibition and bipolar disorder
Q92782643Lithium for schizophrenia: supporting evidence from a 12-year, nationwide health insurance database and from Akt1-deficient mouse and cellular models
Q94569502Stabilization Beyond Mood: Stabilizing Patients With Bipolar Disorder in the Various Phases of Life
Q38957224Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding

Search more.